Protein expression in Mycobacterium tuberculosis differs with growth stage and strain type

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 9, 2002, Pages 869-875

  Pheiffer, Carmen ^a   Betts, Joanna ^a   Lukey, Pauline ^a   van Helden, Paul ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Antigen; Enzyme linked immunosorbent assay: ELISA; Mycobacteria; Protein; Tuberculosis

Indexed keywords

ALANINE DEHYDROGENASE; ALPHA CRYSTALLIN; BACTERIAL ANTIGEN; BCG VACCINE; MONOCLONAL ANTIBODY; BACTERIAL DNA; BACTERIAL PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST RESISTANCE; HOST SUSCEPTIBILITY; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REINFECTION; SERODIAGNOSIS; STRAIN DIFFERENCE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DNA FINGERPRINTING; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; MOLECULAR WEIGHT; MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; SPUTUM;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; HUMANS; MICE; MOLECULAR WEIGHT; MYCOBACTERIUM TUBERCULOSIS; SPUTUM;

EID: 0036405906     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.154     Document Type: Article

References (35)

1. Enarson DA, Rouillon A. The epidemiological basis of tuberculosis control. In: Davies PDO, editor. Clinical tuberculosis. London: Chapman and Hall, 1994:19-32.
2. Iseman MD, Sbarbaro JA. Short-course chemotherapy of tuberculosis. Hail Britannia (and friends)! Am Rev Respir Dis 1991; 143:697-8.
3. Wallis RS, Patil S, Cheon S, Edmonds K, Phillips M, Perkins MD, et al. Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43:2600-6.
4. Bellamy RJ, Hill AV. Host genetic susceptibility to human tuberculosis. Novartis Found Symp 1998; 217:3-13.
5. Hoal-van Helden EG, Hon D, Lewis LA, Beyers N, van Helden PD. Mycobacterial growth in human macrophages: variation according to donor, inoculum and bacterial strain. Cell Biol Int 2001; 25:71-81.
6. Hoal-van Helden EG, Stanton LA, Warren R, Richardson M, van Helden PD. Diversity of in vitro cytokine responses by human macrophages to infection by Mycobacterium tuberculosis strains. Cell Biol Int 2001; 25:83-90.
7. Warren RM, Sampson SL, Richardson M, van der Spuy GD, Lombard CJ, Victor TC, et al. Mapping of 1S6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity. Mol Microbiol 2000; 37:1405-16.
8. Manca C, Tsenova L, Barry III CE, Bergtold A, Freeman S, Haslett PAJ, et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999; 162:6740-6.
9. Van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Eng J Med 1999; 341:1174-9.
10. Du Plessis DG, Warren R, Richardson M, Joubert JJ, van Helden PD. Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS6110 and other repetitive element-based DNA fingerprinting. Tuberculosis 2001; 81:211-20.
11. Delcher AL, Kasi S, Fleischmann RD, Peterson J, White O, Salzberg SL. Alignment of whole genomes. Nucleic Acids Res 1999; 27:2369-76.
12. Brosch R, Pym AS, Gordon SV and Cole ST. The evolution of mycobacterial pathogenicity: clues from comparative genomes. Trends Microbiol 2001; 9:452-8.
13. Kato-Maeda M, Rhee JT, Gingeras TR, Salamon H, Drenkow J, Smittipat N, et al. Comparing genomes within the species Mycobacterium tuberculosis. Genome Res 2001; 11:547-54.
14. Betts JC, Dodson P, Quan S, Lewis AP, Thomas PJ, Duncan K, et al. Comparison of the proteome of Mycobacterium tuberculosis H37Rv with clinical isolate CDC 1551. Microbiology 2000; 146:3205-16.
15. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-44.
16. Yuan Y, Crane DD, Barry III CE. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial α-crystallin homolog. J Bacteriol 1996; 178:4484-92.
17. Wilkinson RJ, Wilkinson KA, De Smet KA, Haslov K, Pasvol G, Singh M, et al. Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol 1998; 48:403-9.
18. Daffé M. The mycobacterial antigen 85 complex - from structure to function and beyond. Trends Microbiol 2000; 8:438-40.
19. Wilkinson RJ, Haslov K, Rappuoli R, Giovannoni F, Narayanan PR, Desai CR, et al. Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol 1997; 35:553-7.
20. Andersen AB, Andersen P, Ljungqvist L. Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun 1992; 60:2317-23.
21. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002; 43:717-31
22. Shinnick TM, Vodkin MH, Williams JC. The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein. Infect Immun 1988; 56:446-51.
23. Heifets LB, Good RC. Current laboratory methods for the diagnosis of tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington DC: American Society for Microbiology, 1994:85-110.
24. Meyers PR, Bourn WR, Steyn LM, van Heiden PD, Beyers AD, Brown GD. Novel method for rapid measurement of growth of mycobacteria in detergent-free media. J Clin Microbiol 1998; 36:2752-4.
25. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
26. Engers HD, Houba V, Bennedsen J, Buchanan TM, Chaparas SD, Kadival G, et al. Results of a World Health Organization-sponsored workshop to characterize antigens recognised by mycobacteria-specific monoclonal antibodies. Infect Immun 1986; 51:718-20.
27. Khanolkar-Young S, Kolk AHJ, Andersen AB, Bennedsen J, Brennan PJ, Rivoire B, et al. Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop. Infect Immun 1992; 60:3925-7.
28. Sonnenberg MG, Beslisle JT. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun 1997; 65:4515-24.
29. Van Soolingen D, Qian L, de Haas PEW, Douglas JT, Traore H, Portaels F, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33:3234-8.
30. Van Rie A, Warren RM, Beyers N, Gie RP, Classen CN, Richardson M, et al. Transmission of a multi-drug resistant Mycobacterium tuberculosis strain resembling "strain w" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis 1999; 180:1608-15.
31. Musser JM, Amin A, Ramaswamy S. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics 2000; 155:7-16.
32. Samanich KM, Beslisle JT, Sonnenberg MG, Keen MA, Zolla-Pazner S, Laal S. Delineation of human antibody responses to culture filtrate antigens of Mycobacterium tuberculosis. J Infect Dis 1998; 178:1534-8.
33. Lyashchenko K, Colangeli R, Houde M, Al Jahdali H, Menzies D, Gennaro ML. Heterogeneous antibody responses in tuberculosis. Infect Immun 1998; 66:3936-40.
34. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991; 59:1905-10.
35. Cappelli G, Volpe P, Sanduzzi A, Sacchi A, Colizzi V, Mariani F. Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97. Infect Immun 2001; 69:7262-70.